Ionis Pharmaceuticals Revenue 2006-2019 | IONS

Ionis Pharmaceuticals annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Ionis Pharmaceuticals revenue for the quarter ending March 31, 2019 was $0.297B, a 105.8% increase year-over-year.
  • Ionis Pharmaceuticals revenue for the twelve months ending March 31, 2019 was $0.752B, a 38.63% increase year-over-year.
  • Ionis Pharmaceuticals annual revenue for 2018 was $0.6B, a 16.63% increase from 2017.
  • Ionis Pharmaceuticals annual revenue for 2017 was $0.514B, a 37.93% increase from 2016.
  • Ionis Pharmaceuticals annual revenue for 2016 was $0.373B, a 31.4% increase from 2015.
Ionis Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $600
2017 $514
2016 $373
2015 $284
2014 $214
2013 $147
2012 $102
2011 $99
2010 $108
2009 $122
2008 $107
2007 $58
2006 $15
2005 $40
Ionis Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q1 2019 $297
Q4 2018 $192
Q3 2018 $145
Q2 2018 $118
Q1 2018 $144
Q4 2017 $168
Q3 2017 $118
Q2 2017 $112
Q1 2017 $116
Q4 2016 $187
Q3 2016 $111
Q2 2016 $38
Q1 2016 $37
Q4 2015 $52
Q3 2015 $49
Q2 2015 $120
Q1 2015 $63
Q4 2014 $85
Q3 2014 $44
Q2 2014 $57
Q1 2014 $28
Q4 2013 $42
Q3 2013 $24
Q2 2013 $38
Q1 2013 $43
Q4 2012 $20
Q3 2012 $12
Q2 2012 $47
Q1 2012 $23
Q4 2011 $32
Q3 2011 $21
Q2 2011 $25
Q1 2011 $21
Q4 2010 $26
Q3 2010 $29
Q2 2010 $24
Q1 2010 $30
Q4 2009 $32
Q3 2009 $27
Q2 2009 $31
Q1 2009 $32
Q4 2008 $30
Q3 2008 $29
Q2 2008 $30
Q1 2008 $18
Q4 2007 $13
Q3 2007 $39
Q2 2007 $4
Q1 2007 $2
Q4 2006 $2
Q3 2006 $3
Q2 2006 $4
Q1 2006 $5
Q4 2005 $15
Q3 2005 $7
Q2 2005 $11
Q1 2005 $7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $9.194B $0.600B
Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.237B 34.65
Astellas Pharma (ALPMY) Japan $28.255B 13.85
Takeda Pharmaceutical (TAK) Japan $27.794B 8.16
Eisai (ESALY) Japan $16.077B 27.64
UCB SA (UCBJF) Belgium $15.866B 0.00
Grifols, S.A (GRFS) Spain $14.700B 18.59
Merck (MKGAF) Germany $13.435B 18.33
IPSEN SA ADR (IPSEY) France $10.629B 0.00
Sage Therapeutics (SAGE) United States $9.716B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.823B 0.00
Catalent (CTLT) United States $7.787B 31.25
Jazz Pharmaceuticals (JAZZ) Ireland $7.540B 10.34
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.878B 9.58
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.944B 17.38
Evotec AG (EVTCY) Germany $4.268B 45.82
Tilray (TLRY) Canada $4.214B 0.00
FibroGen (FGEN) United States $3.929B 0.00
United Therapeutics (UTHR) United States $3.351B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.195B 11.47
Arrowhead Pharmaceuticals (ARWR) United States $2.574B 387.86
PTC Therapeutics (PTCT) United States $2.510B 0.00
Xencor (XNCR) United States $2.499B 68.21
Zogenix (ZGNX) United States $1.999B 0.00
Portola Pharmaceuticals (PTLA) United States $1.776B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.705B 82.56
Enanta Pharmaceuticals (ENTA) United States $1.669B 22.80
Ironwood Pharmaceuticals (IRWD) United States $1.618B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.467B 0.00
USANA Health Sciences (USNA) United States $1.394B 12.12
Corcept Therapeutics (CORT) United States $1.220B 17.41
ArQule (ARQL) United States $1.211B 0.00
Aerie Pharmaceuticals (AERI) United States $1.202B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.105B 3.98
Radius Health (RDUS) United States $1.024B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.973B 0.00
Endo (ENDP) Ireland $0.927B 1.49
Spectrum Pharmaceuticals (SPPI) United States $0.904B 0.00
Concordia (CXRXF) Canada $0.729B 0.00
Organogenesis Holdings (ORGO) United States $0.707B 0.00
Aptorum Group (APM) China $0.672B 0.00
TherapeuticsMD (TXMD) United States $0.603B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.594B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.581B 0.00
GlycoMimetics (GLYC) United States $0.547B 0.00
Translate Bio (TBIO) United States $0.517B 0.00
Akebia Therapeutics (AKBA) United States $0.496B 0.00
ChemoCentryx (CCXI) United States $0.493B 0.00
Karyopharm Therapeutics (KPTI) United States $0.489B 0.00
Dova Pharmaceuticals (DOVA) United States $0.480B 0.00
Dermira (DERM) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.464B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.458B 23.09
Indivior (INVVY) United States $0.434B 1.57
Corbus Pharmaceuticals Holdings (CRBP) United States $0.426B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.421B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.419B 0.00
CV Sciences (CVSI) United States $0.416B 0.00
Flexion Therapeutics (FLXN) United States $0.410B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.400B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Collegium Pharmaceutical (COLL) United States $0.381B 0.00
Innate Pharma SA (IPHYF) France $0.366B 0.00
ImmunoGen (IMGN) United States $0.365B 0.00
Harpoon Therapeutics (HARP) United States $0.365B 0.00
CannTrust Holdings (CTST) Canada $0.364B 0.00
OptiNose (OPTN) United States $0.330B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
KalVista Pharmaceuticals (KALV) United States $0.299B 0.00
Concert Pharmaceuticals (CNCE) United States $0.272B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.260B 0.00
Aratana Therapeutics (PETX) United States $0.244B 0.00
Lannett Co Inc (LCI) United States $0.228B 2.22
Recro Pharma (REPH) United States $0.223B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.219B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.201B 0.00
IMV INC (IMV) Canada $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Calithera Biosciences (CALA) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.160B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.148B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.143B 0.00
Majesco Entertainment (PTE) United States $0.139B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.128B 0.00
DURECT (DRRX) United States $0.107B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.093B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 0.00
Capnia (SLNO) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 63.00
MediWound (MDWD) Israel $0.087B 0.00
Genocea Biosciences (GNCA) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.084B 8.40
Avadel Pharmaceuticals (AVDL) Ireland $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.083B 0.00
Cardiome Pharma (CORV) Canada $0.082B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Novan (NOVN) United States $0.074B 0.00
Neos Therapeutics (NEOS) United States $0.072B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.059B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00